Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 20023094 approvals1 trials

TELCON RF PHARMACEUTICAL. Inc.

Official website

TELCON RF PHARMACEUTICAL is a KOSDAQ-listed firm making RF connectors and cable assemblies alongside liquid pharmaceutical products.

As of 2026-10-10, TELCON RF PHARMACEUTICAL. Inc. has 94 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded 1999, listed on KOSDAQ 2014, TELCON RF PHARMACEUTICAL runs RF component and pharma/bio businesses. Its RF unit makes CABLE ASS'Y and CONNECTOR products; its pharma unit uses a KGMP liquid facility for Algicel, Geodeuaek, Algin-en-aek, Lopota Suspension. It signed an exclusive supply deal with Emmaus Life Sciences for PGLG, API for SCD treatment, worth KRW 36 billion, valid 2017-2032.

Products & technology

  • CABLE ASS'YCable assembly used in wireless telecom equipment manufacturing
  • CONNECTORConnector used in wireless telecom equipment manufacturing
  • 알지셀Liquid formulation pharmaceutical product (KGMP liquid facility)
  • 거드액Liquid formulation pharmaceutical product (KGMP liquid facility)
  • 알긴엔액Liquid formulation pharmaceutical product (KGMP liquid facility)
  • 로포타현탁액Suspension formulation pharmaceutical product (KGMP liquid facility)

Regulatory approvals

data.go.kr

94 Korean MFDS drug approvals · 2002–2024

  • MFDS drugBP Alle solution2024-01-10
    Drug · OTC · Notification202400079
  • MFDS drugLower syrup(acetaminophen)2022-05-12
    Drug · OTC · Notification202201984
  • MFDS drugeF-cool syrup2020-12-02
    Drug · OTC · Notification202008429
  • MFDS drugef-cough syrupRevoked2020-11-27
    Drug · OTC · Notification202008299
  • MFDS drugef-nose syrupRevoked2020-11-26
    Drug · OTC · Notification202008260
  • MFDS drugE.B Pyeon Sol. 0.12%(Chlorhexidine Gluconate Solution)Revoked2020-11-25
    Drug · OTC · Notification202008210
  • MFDS drugBenaniRevoked2020-11-25
    Drug · OTC · Notification202008211
  • MFDS drugJang Mi-In syrup(Lactulose concentration solution)Revoked2020-11-09
    Drug · OTC · Notification202007666
  • MFDS drugCellason Cream2020-11-05
    Drug · OTC · Notification202007594
  • MFDS drugDamoavita syrupRevoked2020-11-04
    Drug · OTC · Notification202007537
  • MFDS drugTelluna Cap. 50mg(Fluconazole)Revoked2020-10-13
    Drug · Prescription · Approval202006968
  • MFDS drugSsenpowervita soft capsule2020-07-14
    Drug · OTC · Notification202005041
Show 68 more
  • MFDS drugAllinecin Inj.(Fursultiamine)(Ampule)2020-07-03
    Drug · Prescription · Notification202004834
  • MFDS drug크래리정250mg(클래리트로마이신)Revoked2020-05-11
    Drug · Prescription · Approval202003409
  • MFDS drug텔미로우플러스정40/12.5밀리그램Revoked2020-02-20
    Drug · Prescription · Approval202001194
  • MFDS drug텔미로우플러스정80/12.5밀리그램Revoked2020-02-19
    Drug · Prescription · Approval202001186
  • MFDS drug탐스콘서방캡슐0.2밀리그램(탐스로신염산염)2020-02-03
    Drug · Prescription · Approval202000539
  • MFDS drug차배비플러스시럽Revoked2020-01-30
    Drug · OTC · Notification202000488
  • MFDS drug세라코프시럽(딸기향, 바나나향)Revoked2020-01-08
    Drug · OTC · Notification202000133
  • MFDS drugRosumedi Tablet 5mg2019-12-19
    Drug · Prescription · Approval201908546
  • MFDS drug로수메디정10밀리그램(로수바스타틴칼슘)2019-12-14
    Drug · Prescription · Approval201908417
  • MFDS drug두리드정0.5밀리그램(두타스테리드)2019-12-04
    Drug · Prescription · Approval201908233
  • MFDS drug세나쿨시럽Revoked2019-11-22
    Drug · OTC · Notification201908050
  • MFDS drug텔콘알에프피나스테리드정5밀리그램2019-11-13
    Drug · Prescription · Approval201907898
  • MFDS drugSteri Tablet 1mg2019-11-13
    Drug · Prescription · Approval201907899
  • MFDS drugAtocell-S Tablet 20mg2019-11-11
    Drug · Prescription · Approval201907848
  • MFDS drug셀로펜정60밀리그램(록소프로펜나트륨수화물)Revoked2019-10-15
    Drug · Prescription · Approval201907265
  • MFDS drug차배비시럽2019-09-09
    Drug · OTC · Notification201906376
  • MFDS drug텔미로우정40밀리그램(텔미사르탄)2019-09-06
    Drug · Prescription · Approval201906333
  • MFDS drug텔미로우정80밀리그램(텔미사르탄)2019-09-06
    Drug · Prescription · Approval201906334
  • MFDS drug레보유로정(레보플록사신수화물)Revoked2019-08-05
    Drug · Prescription · Approval201905517
  • MFDS drug로우스타정40/5밀리그램2019-07-24
    Drug · Prescription · Approval201905277
  • MFDS drug셀라베정20밀리그램(라베프라졸나트륨)2019-07-16
    Drug · Prescription · Approval201904754
  • MFDS drug로우스타정40/10밀리그램2019-07-08
    Drug · Prescription · Approval201904619
  • MFDS drug로우스타정80/5밀리그램Revoked2019-07-08
    Drug · Prescription · Approval201904618
  • MFDS drug노페라정Revoked2019-05-31
    Drug · Prescription · Notification201903607
  • MFDS drugSelrabe TabletRevoked2019-04-18
    Drug · Prescription · Approval201902398
  • MFDS drugGlutatine Tablet 100mg2019-04-02
    Drug · OTC · Notification201902007
  • MFDS drugMetiro TabletRevoked2019-03-21
    Drug · Prescription · Approval201901707
  • MFDS drug사포진정(사르포그렐레이트염산염)2019-03-20
    Drug · Prescription · Approval201901686
  • MFDS drugMedimineral InjectionRevoked2019-03-04
    Drug · Prescription · Notification201901316
  • MFDS drug씨비타주(아스코르브산)Revoked2019-02-22
    Drug · Prescription · Notification201901125
  • MFDS drug아셀렌주(아셀렌산나트륨오수화물)Revoked2019-02-20
    Drug · Prescription · Notification201901031
  • MFDS drug글루타틴정(글루타티온(환원형))Revoked2019-02-14
    Drug · OTC · Notification201900917
  • MFDS drug토피정100밀리그램(토피라메이트)Revoked2019-01-23
    Drug · Prescription · Approval201900603
  • MFDS drugZeroal TabletRevoked2019-01-18
    Drug · OTC · Notification201900244
  • MFDS drug토피정25밀리그램(토피라메이트)Revoked2019-01-16
    Drug · Prescription · Approval201900207
  • MFDS drug아라미스정480밀리그램(알티옥트산트로메타민염)Revoked2019-01-09
    Drug · Prescription · Approval201900078
  • MFDS drug세로틴캡슐20밀리그램(플루옥세틴염산염)Revoked2019-01-09
    Drug · Prescription · Approval201900086
  • MFDS drug셀티린정(세티리진염산염)Revoked2019-01-08
    Drug · OTC · Notification201900054
  • MFDS drug스타진코정Revoked2018-12-11
    Drug · Prescription · Approval201805029
  • MFDS drug세나코시럽(딸기향, 포도향)Revoked2018-11-22
    Drug · OTC · Notification201804643
  • MFDS drug비우라정Revoked2018-10-29
    Drug · OTC · Notification201804273
  • MFDS drug카세린에프정Revoked2018-10-22
    Drug · OTC · Notification201804158
  • MFDS drug셀그린캡슐Revoked2018-10-22
    Drug · OTC · Notification201804161
  • MFDS druglala gold liquid2018-08-24
    Drug · OTC · Notification201803438
  • MFDS drugTelogrel Tablet2018-05-11
    Drug · Prescription · Approval201802008
  • MFDS drugGascone Solution2018-04-04
    Drug · OTC · Notification201801490
  • MFDS drug셀록신정(록시트로마이신)2018-03-28
    Drug · Prescription · Approval201801363
  • MFDS drug에스페질정5밀리그램(도네페질염산염수화물)2017-12-21
    Drug · Prescription · Approval201708482
  • MFDS drug에스페질정10밀리그램(도네페질염산염수화물)2017-08-22
    Drug · Prescription · Approval201706736
  • MFDS drugAtocel-S Tab. 10mg2017-06-26
    Drug · Prescription · Approval201704784
  • MFDS drugEldowon Capsule2016-06-01
    Drug · OTC · Notification201603171
  • MFDS drugLeicaine Cream2016-05-30
    Drug · Prescription · Notification201603047
  • MFDS drugHepagel Solution2015-07-09
    Drug · OTC · Approval201504728
  • MFDS drugcelbecal ointment2015-04-13
    Drug · Prescription · Approval201502002
  • MFDS drug엘도카인카타플라스마(리도카인)2015-03-26
    Drug · Prescription · Notification201501623
  • MFDS drug셀티스셀자탄정(로사르탄칼륨)2015-03-13
    Drug · Prescription · Approval201501321
  • MFDS drug셀티브캡슐200밀리그램(세레콕시브)2015-03-12
    Drug · Prescription · Approval201501312
  • MFDS drug셀피리드정(글리메피리드)2015-02-25
    Drug · Prescription · Approval201501001
  • MFDS drug셀리손정(에페리손염산염)2015-02-24
    Drug · Prescription · Approval201500947
  • MFDS drug셀티스파모티딘정20밀리그램(파모티딘)2015-01-28
    Drug · Prescription · Approval201500465
  • MFDS drug셀자틴정(니자티딘)Revoked2015-01-07
    Drug · Prescription · Approval201500072
  • MFDS drug셀라스틴정1밀리그램(아젤라스틴염산염)2014-12-17
    Drug · Prescription · Approval201405910
  • MFDS drug셀코나졸정100밀리그램(이트라코나졸)2014-12-08
    Drug · Prescription · Approval201405797
  • MFDS drug몸싹정Revoked2014-10-28
    Drug · OTC · Notification201404999
  • MFDS drug덴타가드플러스캡슐Revoked2014-10-27
    Drug · OTC · Notification201404973
  • MFDS drug에피지온정(에피나스틴염산염)2014-10-14
    Drug · Prescription · Approval201404704
  • MFDS drug라비트라정Revoked2014-10-01
    Drug · Prescription · Approval201404551
  • MFDS drug리스토액(시트룰린말산염)2014-09-24
    Drug · OTC · Notification201404360

Showing the 80 most recent of 94 records.

Clinical trials

data.go.kr

1 MFDS clinical trial authorisations · 2021 (Phase 1 1)

  • Phase 1렌질루맙2021-07-21

    2 trial sites

Key disclosures

KRX KIND via OpenDART
Show 6 more events

Patents

KIPRIS · applicant-matched
Show 42 more patents

AI reads

MAA server logs · IP-verified
56
Times AI engines pulled TELCON RF PHARMACEUTICAL. Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

53
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 0
Last 7 days
50
live 3
Last 30 days
56
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot47
  • MicrosoftBingbot2
  • AnthropicClaudeBot2
  • PerplexityPerplexityBot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for TELCON RF PHARMACEUTICAL. Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition